ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
India's Central Drugs Standard Organisation (CDSCO) has not adopted AI for regulatory approvals, relying on scientific review, the government told Parliament. New CDSCO guidance requires AI-enabled medical device software developers to disclose model workings, training data, and risk handling, plus post-market monitoring.
Tap to vote and see what everyone thinks.
Summary by ByteBrief